Fujifilm Corporation

Kyoto Prefectural Public University Corporation

Tsukasa Kitahashi

Kentaro Nakamura

Shinji Mima

Takeshi Matsumoto

Mikinaga Mori

Takahiro Sekiguchi

Yoshihide Iwaki

Yi Hu

Hisao Arai

Ken Okada

Rie Hando

Daisuke Kami

Satoshi Gojo

Mayumi Katayama

An object of the present invention is to provide an excellent treatment agent for a lysosomal storage disease. According to the present invention, there is provided a treatment agent for a lysosomal storage disease including a cell structure which includes a plurality of biocompatible polymer blocks and a plurality of cells of at least one type and in which at least one of the polymer blocks is disposed in gaps between the plurality of cells.

Treatment agent for lysosomal storage disease

An object of the present invention is to provide an anti-tumor agent and an anti-tumor kit which have superior anti-tumor effect as compared with a therapy with gemcitabine, paclitaxel or a combination thereof; as well as an anti-tumor effect enhancer. According to the present invention, provided is an anti-tumor agent including paclitaxel or a salt thereof and 1-(2-deoxy-2-fluoro-4-thio-&#x3b2;-D-arabinofuranosyl)cytosine or a salt or prodrug thereof.

Anti-tumor agent, anti-tumor effect enhancer, and anti-tumor kit

A measuring device includes a measuring unit that measures the morphology of a convex portion, and a position fixing unit that includes an opening in which the convex portion is to be disposed and a fixing member which includes the opening at a center thereof and against which the periphery of the convex portion is to be pressed. The size of the opening of the position fixing unit is capable of being changed.

Measuring device

An object of the present invention is to provide a tumor therapeutic agent and a kit which have superior antitumor effects as compared with gemcitabine, a taxane antitumor agent, and a combination therapy thereof which have been put on the market. According to the present invention, there is provided a tumor therapeutic agent obtained by combining a taxane antitumor agent with a liposome composition in which gemcitabine or a salt thereof is contained in a liposome.

Tumor therapeutic agent and kit containing gemcitabine liposome composition

Growing community of inventors

Ashigarakami-gun, Japan

Tsukasa Kitahashi